Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin-induced weight gain determinants in type 2 diabetes
NL-OMON31007Not yet recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Sep 2007
- Countries
- 1
01
Overview
Open-label trial in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Radboud University Medical Center. Primary endpoint: Intracellular liver lipid levels. Planned start Sep 2007; status: not yet recruiting.
02
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NL-OMON31007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON31007.